RSS worker’s murder: Cops illegally detaining innocent Muslims, says SDPI

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Kasaragod, Jun 2: Kumbala police on Tuesday arrested 20 persons on charges of misbehaving and obstructing a medical team who were on official duty for Covid-19.

Police sources said the incident occurred at Kumbala beach near here on Monday evening when a group of locals misbehaved and obstructed an eight-member medical team, comprising of doctors and health workers, from carrying out a survey to asertain whether there has been a community spread of Covid-19 in that locality.

The health team was on a mission to gather data of people who had interacted with expatriates after they had returned to hometown recently.

Mangaluru, Jul 12: The Expert Committee set up by the District authorities to inquire into death due to Covid-19 in Dakshina Kannada district declared that the death was due to patients late reporting to the hospitals and severe co-morbidities.

''Many were scared to visit the hospitals for treatment. Any patient suffering from fever, cold should stop self-medication and seek the advice of doctors. From what we have observed, the mortality was among patients who reported late to hospitals. Many had ignored symptoms assuming it to be a common cold,'' Expert Committee members Dr Hansraj Alva and Dr Muralidhar Yadiyal told mediapersons on Saturday night.

Wenlock Hospital Superintendent Dr Sadashiv said of the 38 deaths reported in the District, the expert committee had analysed 35 deaths. 9 persons who died are below 50 years old, 10 are in the age group of 50 to 60 years, 11 in the age group of 60 to 70 and five in the age group of above 70 years.